Therefore, the SLCO1B1 polymorphisms and plasma levels of N‐desmethylclozapine as well as clozapine in patients with schizophrenia should be assayed for optimizing clozapine therapy. This evidence concerns the gene SLCO1B1 and schizophrenia.